Novo Nordisk declined to comment on when the company would end production of human insulin pens, adding that the pens were different from those used for its hugely popular GLP-1 drugs, Ozempic and ...

Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract ... and infusion systems in the diabetes space. The company sold its pen needles and blood glucose monitoring systems ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Novo Nordisk is to launch “connected” insulin pens, responding for demands from patients for devices able to communicate with glucose monitoring systems and glucose meters. The Danish pharma ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular ... such as those who are afraid of needles, could soon access treatment in a more convenient way. " ...